Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology.
By A. Shabsigh, R. Korets, K. Vora, C. Brooks, A. Cronin, C. Savage, G. Raj, B. Bochner, G. Dalbagni, H. Herr and 1 more. European Urology, 2009
1,351 citations recorded by the source corpus.
Subfields: Epidemiology, Surgery
View Paper: https://www.semanticscholar.org/paper/367e89bc9edd14fcecf58e4ee014e05a564a785a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- A. Zietman
- Todd M. Morgan
- Roger Chou
- Sam S. Chang
- J. Michalski
- R. Dreicer
- Seth P. Lerner
- Ashish M. Kamat
Citations in the corpus
- Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: Aua/Asco/Astro/Suo Guideline (2017, background): “Patients considering a radical cystectomy should be counseled regarding the high rate of complications, both acute and chronic.(19,20) This is”